Effects of tetrandrine on gastric mucosa and liver in portal hypertensive rats

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

165

HTML

1735

Tables (1-3)

197

Sum=2097

Sep 15, 1997 (publication date) through Feb 4, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Traditional Medicine

World J Gastroenterol. Sep 15, 1997; 3(3): 192-194
Published online Sep 15, 1997. doi: 10.3748/wjg.v3.i3.192

Table 3 The liver fibrosis degree

^aP < 0.05,

^bP < 0.01, vs portal hypertensive (PHT) controls group;

^cP < 0.05,

^dP < 0.01, vs propranolol group.

Citation: Mu Y, Shen YZ, Chu YF. Effects of tetrandrine on gastric mucosa and liver in portal hypertensive rats. World J Gastroenterol 1997; 3(3): 192-194
URL: https://www.wjgnet.com/1007-9327/full/v3/i3/192.htm
DOI: https://dx.doi.org/10.3748/wjg.v3.i3.192